Effects of infliximab infusion on clinical symptom scores and serum cytokines in patients with inflammatory bowel disease

Intravenous INF effectively improves clinical symptoms and modulates inflammatory cytokines in IBD patients, with favorable safety and increasing efficacy over time. However, the limited sample size and lack of long-term data warrant further validation in larger, prospective multicenter studies.